Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

Peer Review reports

Original Submission
14 Jul 2015	Submitted	Original manuscript
1 Oct 2015	Reviewed	Reviewer Report - M Druce
26 Oct 2015	Reviewed	Reviewer Report - Mark Gurnell
12 Jan 2016	Author responded	Author comments - Marcello D Bronstein
Resubmission - Version 2
12 Jan 2016	Submitted	Manuscript version 2
22 Feb 2016	Author responded	Author comments - Marcello D Bronstein
Resubmission - Version 3
22 Feb 2016	Submitted	Manuscript version 3
Publishing
14 Mar 2016	Editorially accepted
2 Apr 2016	Article published	10.1186/s12902-016-0096-8

Back to article page